Revolution Medicines (RVMD) Assets (2019 - 2026)
Revolution Medicines (RVMD) reported Assets of $4.32 billion for Q2 2026, up 77.9% from $2.43 billion a year earlier and up 91.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines posted Assets of $2.35 billion, down 8.0% from FY2024.
- Assets has a five-year compound annual growth rate of 32.9% (FY2020 to FY2025).
- By year, Assets came in at $2.56 billion in FY2024 (+24.1%), $2.06 billion in FY2023 (+153.9%), $811.93 million in FY2022 (+10.0%) and $737.99 million in FY2021 (+30.1%).
- The Q2 2026 figure ranks as the highest quarterly Assets in data going back to Q4 2019.
- Year over year, Assets gained in six of the last eight quarters, with growth averaging 31.8%.
- The high point for year-over-year Assets in five years was Q4 2023 (growth of 153.9%); the low point was Q2 2022 (a decline of 18.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.25 billion (Q1 2026), $2.35 billion (Q4 2025) and $2.25 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 4.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Bn |
| Mar 31, 2026 | 2.25 Bn |
| Dec 31, 2025 | 2.35 Bn |
| Sep 30, 2025 | 2.25 Bn |
| Jun 30, 2025 | 2.43 Bn |
| Mar 31, 2025 | 2.37 Bn |
| Dec 31, 2024 | 2.56 Bn |
| Sep 30, 2024 | 1.76 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 2.06 Bn |
| Sep 30, 2023 | 984.23 Mn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 811.93 Mn |
| Sep 30, 2022 | 825.91 Mn |
| Jun 30, 2022 | 632.80 Mn |
| Mar 31, 2022 | 682.77 Mn |
| Dec 31, 2021 | 737.99 Mn |
| Sep 30, 2021 | 734.98 Mn |
API Access
Revolution Medicines Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();